Show simple item record

Vorinostat in combination with lenalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma

dc.contributor.authorSiegel, D Sen_US
dc.contributor.authorRichardson, Pen_US
dc.contributor.authorDimopoulos, Men_US
dc.contributor.authorMoreau, Pen_US
dc.contributor.authorMitsiades, Cen_US
dc.contributor.authorWeber, Den_US
dc.contributor.authorHoup, Jen_US
dc.contributor.authorGause, Cen_US
dc.contributor.authorVuocolo, Sen_US
dc.contributor.authorEid, Jen_US
dc.contributor.authorGraef, Ten_US
dc.contributor.authorAnderson, K Cen_US
dc.date.accessioned2014-05-06T16:18:23Z
dc.date.issued2014en_US
dc.identifier.citationSiegel, D. S., P. Richardson, M. Dimopoulos, P. Moreau, C. Mitsiades, D. Weber, J. Houp, et al. 2014. “Vorinostat in combination with lenalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma.” Blood Cancer Journal 4 (4): e202. doi:10.1038/bcj.2014.23. http://dx.doi.org/10.1038/bcj.2014.23.en
dc.identifier.issn2044-5385en
dc.identifier.urihttp://nrs.harvard.edu/urn-3:HUL.InstRepos:12153006
dc.description.abstracten
dc.language.isoen_USen
dc.publisherNature Publishing Groupen
dc.relation.isversionofdoi:10.1038/bcj.2014.23en
dc.relation.hasversionhttp://www.ncbi.nlm.nih.gov/pmc/articles/PMC4003417/pdf/en
dash.licenseLAAen_US
dc.titleVorinostat in combination with lenalidomide and dexamethasone in patients with relapsed or refractory multiple myelomaen
dc.typeJournal Articleen_US
dc.description.versionVersion of Recorden
dc.relation.journalBlood Cancer Journalen
dc.date.available2014-05-06T16:18:23Z
dc.identifier.doi10.1038/bcj.2014.23*
dash.authorsorderedfalse


Files in this item

Thumbnail
Name:
4003417.pdf
Size:
59.83Kb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record